EGRX

アフターアワーズ： 1.99

Eagle Pharmaceuticals Inc (EGRX)

概要ニュース株価時系列オプションチェーン Financials ディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Eagle Pharmaceuticals Inc Stock (EGRX) Company Profile

Eagle Pharmaceuticals Inc

Healthcare (1153)

EGRX's Discussions on Twitter

EGRX を他の銘柄と比較する

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
EGRX Eagle Pharmaceuticals Inc	1.99	0	257.55M	11.95M	-9.39M	0.91
ZTS Zoetis Inc	159.27	70.23B	9.29B	2.52B	2.28B	5.57
HLN Haleon Plc Adr	10.74	48.23B	14.35B	1.85B	0	0.4023
TAK Takeda Pharmaceutical Co Adr	14.36	48.22B	30.08B	710.16M	4.45B	0.2182
TEVA Teva Pharmaceutical Industries Ltd Adr	16.93	18.57B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	301.42	13.29B	2.76B	1.11B	898.10M	22.77

Eagle Pharmaceuticals Inc Stock (EGRX) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2021-04-07	再開されました	RBC Capital Mkts	Outperform
2018-11-01	ダウングレード	Cantor Fitzgerald	Overweight → Neutral
2018-10-31	ダウングレード	Piper Jaffray	Overweight → Neutral
2018-03-21	繰り返されました	Mizuho	Underperform
2017-11-09	繰り返されました	RBC Capital Mkts	Outperform
2017-09-06	繰り返されました	Mizuho	Underperform
2017-07-27	繰り返されました	Mizuho	Underperform
2017-07-27	繰り返されました	RBC Capital Mkts	Outperform
2017-05-09	繰り返されました	RBC Capital Mkts	Outperform
2017-01-09	ダウングレード	Mizuho	Neutral → Underperform
2016-11-16	ダウングレード	Mizuho	Buy → Neutral
2016-11-03	アップグレード	Mizuho	Neutral → Buy
2016-11-03	繰り返されました	RBC Capital Mkts	Outperform
2016-10-26	繰り返されました	Mizuho	Buy
2016-08-16	繰り返されました	Mizuho	Neutral
2016-06-20	ダウングレード	Mizuho	Buy → Neutral
2016-05-10	繰り返されました	RBC Capital Mkts	Outperform
2016-03-18	繰り返されました	Mizuho	Buy
2016-02-26	繰り返されました	Mizuho	Buy
2015-12-09	開始されました	Mizuho	Buy
2015-07-29	繰り返されました	Piper Jaffray	Overweight

Eagle Pharmaceuticals Inc (EGRX) 最新ニュース

Eagle Pharmaceuticals Inc (EGRX) 財務データ

Eagle Pharmaceuticals Inc (EGRX)

Eagle Pharmaceuticals Inc Stock (EGRX) Company Profile

EGRX を他の銘柄と比較する

Eagle Pharmaceuticals Inc Stock (EGRX) Upgrades & Downgrades

Eagle Pharmaceuticals Inc (EGRX) 最新ニュース

EGRX STOCKHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Eagle Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Eagle Pharmaceuticals (NASDAQ:EGRX) Now Covered by Analysts at StockNews.com - Defense World

INVESTOR ALERT: Potential Recovery for Eagle Pharmaceuticals, Inc. (EGRX) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Eagle Pharmaceuticals, Inc. (EGRX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

INVESTOR ALERT: Levi & Korsinsky Notifies Shareholders of Eagle Pharmaceuticals, Inc. (EGRX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Press Release Distribution & PR Platform - ACCESS Newswire

Eagle Pharmaceuticals (NASDAQ:EGRX) Coverage Initiated at StockNews.com - The AM Reporter

Eagle Pharmaceuticals Shares Turn Positive After Positive 2022 Outlook - marketscreener.com

Eagle Pharmaceuticals (NASDAQ:EGRX) Coverage Initiated by Analysts at StockNews.com - Defense World

Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender AgreementHagens Berman - ACCESS Newswire

Latham Watkins Advises Eagle Pharmaceuticals in Royalty Monetization With Blue Owl Capital - Latham & Watkins LLP

Eagle Pharmaceuticals Announces $69 Mln Agreement To Monetize Bendeka Royalties - marketscreener.com

Eagle Pharmaceuticals Announces $69 Million Agreement to Monetize BENDEKA® Royalties - The Manila Times

Major Cash Injection: Eagle Pharma Lands $69M Through Strategic Royalty Sale - Stock Titan

StockNews.com Initiates Coverage on Eagle Pharmaceuticals (NASDAQ:EGRX) - Defense World

Eagle Pharmaceuticals (NASDAQ:EGRX) Share Price Crosses Below 200-Day Moving Average – Here’s Why - Defense World

Eagle Pharmaceuticals Announces Amendment to Limited Duration Stockholder Rights Plan - The Manila Times

Eagle Pharmaceuticals announces amendment to limited duration stockholder rights plan - Marketscreener.com

Eagle Pharmaceuticals Doubles Anti-Takeover Protection to $20 in Rights Plan Update - Stock Titan

Eagle Pharmaceuticals (NASDAQ:EGRX) Stock Crosses Below Two Hundred Day Moving Average – Here’s Why - Defense World

Eagle Pharmaceuticals (NASDAQ:EGRX) Now Covered by StockNews.com - Defense World

Eagle Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Eagle Pharmaceuticals (NASDAQ:EGRX) Earns Hold Rating from Analysts at StockNews.com - Defense World

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Eagle Pharmaceuticals, Inc. (EGRX) - ACCESS Newswire

SHAREHOLDER ALERT: Potential Recovery for Eagle Pharmaceuticals, Inc. (EGRX) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

EGRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Eagle Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Class Action Filed Against Eagle Pharmaceuticals, Inc. (EGRX)February 9, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

StockNews.com Begins Coverage on Eagle Pharmaceuticals (NASDAQ:EGRX) - Defense World

Eagle Pharmaceuticals, Inc. Enters Third Amended and Restated Credit Agreement - Marketscreener.com

Jane Street Group LLC Makes New Investment in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World

JPMorgan Chase & Co. Sells 63,155 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - Defense World

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09% - MSN

Antiemetics Drugs Market Size & Share Report, 2024 – 2032 - Global Market Insights

Last Week's Biggest Stock Movers: Eagle, Noodles & Co. - AOL

Eagle Pharmaceuticals Inc (EGRX) 財務データ

収益

当期純利益

現金流量

EPS

EGRXに似た銘柄